Original Research J Clin Psychiatry August 2026

Time Trends in Maternal Attention-Deficit/Hyperactivity Disorder and Medication Use in Pregnancy

JCP 2026;87(3):10.4088/JCP.26m16321

Full Article Read the complete peer-reviewed article in J Clin Psychiatry. JCP 2026;87(3):10.4088/JCP.26m16321 Clinical Summary Pregnant women with attention-deficit/hyperactivity disorder are becoming a larger part of perinatal practice, and many are weighing whether to continue stimulant treatment while facing limited pregnancy-specific safety data. This study quantifies how fast maternal ADHD and stimulant use in pregnancy are rising, which matters for counseling, care planning, and service capacity. FAQ How much did maternal ADHD in pregnancy increase over time in this study? 11 questions
Key Takeaways Pregnant patients with maternal ADHD differed substantially from those without ADHD, including younger median age (23 vs 31 years), more primiparity (56.1% vs. 42.9%), greater concentration in the lowest neighborhood income quintile (33.1% vs 19.6%), and much higher psychiatric comorbidity (86.8% vs 42.9% for psychiatric history). 6 takeaways Clinical Guide How should clinicians structure counseling for pregnant patients with attention-deficit/hyperactivity disorder who are using stimulant medication before conception or during pregnancy? 8 steps
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe